- Home
- ONC vs PHG Comparison
ONC vs PHG Comparison
Compare ONC & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- PHG
- Stock Information
- Founded
- ONC 2010
- PHG 1891
- Country
- ONC Cayman Islands
- PHG Netherlands
- Employees
- ONC N/A
- PHG N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- PHG Medical Electronics
- Sector
- ONC Health Care
- PHG Health Care
- Exchange
- ONC Nasdaq
- PHG Nasdaq
- Market Cap
- ONC 26.9B
- PHG 21.7B
- IPO Year
- ONC N/A
- PHG N/A
- Fundamental
- Price
- ONC $231.99
- PHG $24.55
- Analyst Decision
- ONC Strong Buy
- PHG Buy
- Analyst Count
- ONC 7
- PHG 3
- Target Price
- ONC $326.43
- PHG N/A
- AVG Volume (30 Days)
- ONC 471.3K
- PHG 896.8K
- Earning Date
- ONC 05-07-2025
- PHG 05-06-2025
- Dividend Yield
- ONC N/A
- PHG 3.07%
- EPS Growth
- ONC N/A
- PHG N/A
- EPS
- ONC N/A
- PHG 0.43
- Revenue
- ONC $4,175,868,000.00
- PHG $19,433,635,964.00
- Revenue This Year
- ONC $860.73
- PHG $5.75
- Revenue Next Year
- ONC $19.79
- PHG $4.55
- P/E Ratio
- ONC N/A
- PHG $56.51
- Revenue Growth
- ONC 51.16
- PHG N/A
- 52 Week Low
- ONC $141.31
- PHG $20.96
- 52 Week High
- ONC $287.88
- PHG $32.91
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- PHG 49.57
- Support Level
- ONC N/A
- PHG $23.83
- Resistance Level
- ONC N/A
- PHG $25.86
- Average True Range (ATR)
- ONC 0.00
- PHG 0.38
- MACD
- ONC 0.00
- PHG 0.01
- Stochastic Oscillator
- ONC 0.00
- PHG 35.47
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About PHG Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.